Researchers of a recent study found that higher ambient exposure to fine particulate matter (PM2.5) was associated with an increased risk of cancer-related death in patients diagnosed with non–small cell lung cancer (NSCLC). Using data from 18,585 patients in the California Cancer Registry (2017–2020), researchers measured PM2.5 exposure during the 12 months following diagnosis by combining satellite data, monitoring stations, sensors, and predictive models. Results showed that higher annual average PM2.5 exposure increased the hazard of cancer-related death by nearly 20%, and this association was consistent across subgroups. These findings highlight the serious public health risks posed by increasing wildfire-related air pollution.
Interestingly, when researchers examined short-term, wildfire-driven spikes in PM2.5 exposure (≥55 μg/m³), they observed an unexpected survival benefit. For every 10 days of such exposure, the hazard of cancer-related death decreased by 7%. This effect was most pronounced in patients with stage IV disease, those treated with immunotherapy, and individuals with a history of tobacco use—where some subgroups showed a 21% reduction in cancer-related mortality. While the biological explanation remains unclear, investigators speculated that wildfire-driven PM2.5 might modulate the immune microenvironment in ways that synergize with immunotherapy, underscoring the need for further research into these complex and paradoxical findings.
Reference: Cipriano J. Does Exposure to Wildfire-Dominated, Inhalable, Fine Particulate Matter Impact Survival in NSCLC? The ASCO Post. Published July 25, 2025. Accessed August 19, 2025. https://ascopost.com/issues/july-25-2025/does-exposure-to-wildfire-dominated-inhalable-fine-particulate-matter-impact-survival-in-nsclc/
